Phinnara Has

Mr. Phinnara Has

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
EWErika F. Werner
Erika F. Werner
PHPhinnara Has
Phinnara Has
DRDwight Rouse
Dwight Rouse
MCMelissa A. Clark
Melissa A. Clark

1 April 2017 in Pathology - Research and Practice
Verified
Journal Article
Closed access
SRSanjita Ravishankar
Sanjita Ravishankar
AMAlison Migliori
Alison Migliori
JSJudy Struminsky
Judy Struminsky
PHPhinnara Has
Phinnara Has
CSC. James Sung
C. James Sung
MHMai He
Mai He

25 January 2022 in BMC Medical Education
Verified
Journal Article
Open access
PDF file
JDJia Jennifer Ding
Jia Jennifer Ding
PHPhinnara Has
Phinnara Has
BHB. Star Hampton
B. Star Hampton
DBDayna Burrell
Dayna Burrell
Background: Travel restrictions amidst the COVID-19 pandemic reshaped interviewing for fellowships into a predominantly virtual process. How this impacts Obstetrics and Gynecology (OB/GYN) resident approaches to fellowship application and Match navigation is largely unknown. Methods: We performed a cross-sectional survey study of fourth year OB/GYN residents in the United States who participated in at least one virtual fellowship interview in 2020. We collected information regarding demographics, application strategy, perceived strengths and weaknesses of virtual interviews, and confidence with rank list creation. Descriptive statistics were used for categorical variables and responses pre- and post-Match were compared using Fisher’s exact test. Results: Seventy-five out of an estimated 490 applicants (~ 15% response rate) completed the survey. Of the respondents, 65.3% felt they interviewed at more programs virtually than they would anticipate completing in person, but perceived less confidence in having the necessary information (n = 45, 60%) or understanding the culture of programs (n = 59, 78.7%) to create a rank list. Cost savings were the main benefit of virtual interviews (n = 50, 66.7%), and inability to get a true “feel” for a program was the biggest limitation (n = 43, 57.3%). A majority (46.7%) advocate for a future hybrid interview process. Conclusions: OB/GYN residents pursuing fellowship reported interviewing at more programs during the virtual season, but had less confidence with rank list creation. Cost savings benefits are weighed against difficulty getting a “feel” for programs virtually. Most would advocate for a future hybrid interview process.

31 July 2024 in Intestinal Research
Verified
Journal Article
Open access
PDF file
RRRahiya Rehman
Rahiya Rehman
MRMuhammad Safwan Riaz
Muhammad Safwan Riaz
DEDyadin Esharif
Dyadin Esharif
PHPhinnara Has
Phinnara Has
MHMichael Herzlinger
Michael Herzlinger
SSShova Subedi
Shova Subedi
Background/Aims: To describe the role of ustekinumab in inducing remission and endoscopic healing in anti-tumor necrosis factor α nonresponsive pediatric ulcerative colitis patients at a tertiary care inflammatory bowel disease center. Methods: A retrospective chart review was performed on patients with ulcerative colitis receiving ustekinumab. Primary outcome was steroidfree clinical remission at follow-up. Secondary outcomes were biochemical remission and endoscopic healing. Results: Ten children were analyzed; 7 (70%) had ulcerative colitis, and 3 (30%) had inflammatory bowel disease unspecified with colitis. Median follow-up period was 56 weeks. Nine patients (90%) achieved steroid-free clinical remission and biochemical remission. Seven patients had follow-up colonoscopies, out of which 6 (86%) achieved endoscopic remission, while 1 (14%) underwent colectomy. Out of the 3 patients without a follow-up colonoscopy, fecal calprotectin levels downtrended to < 150 mg/kg in 2 patients and < 400 mg/kg in 1 patient from baseline level of > 2,000 mg/kg. Conclusions: Ustekinumab appears efficacious in achieving not only clinical and biochemical remission but also has promising role in inducing endoscopic healing end point in patients who fail other biologics.

1 June 2022 in Radiology: Cardiothoracic Imaging
Verified
Journal Article
Closed access
YPYash R. Patel
Yash R. Patel
NSNishant R. Shah
Nishant R. Shah
KLKristin Lombardi
Kristin Lombardi
SASaurabh Agarwal
Saurabh Agarwal
PHPhinnara Has
Phinnara Has
MAMichael K. Atalay
Michael K. Atalay
By comparing phenotypic clinical characteristics and cardiovascular magnetic resonance (CMR) findings in 14 patients with COVID-19 mRNA vaccine-associated myocarditis to 14 patients with acute myoc...

19 February 2026 in Circulation: Heart Failure
Verified
Journal Article
Closed access
CMChirag Mehta
Chirag Mehta
PHPhinnara Has
Phinnara Has
AMAryan Mehta
Aryan Mehta
IVIrene Vargas
Irene Vargas
BOBrian Osorio
Brian Osorio
Saraschandra VallabhajosyulaSaraschandra Vallabhajosyula
Saraschandra Vallabhajosyula
BACKGROUND: There are limited data on the etiology, management, and outcomes of Society for Cardiovascular Angiography and Interventions (SCAI) B cardiogenic shock. METHODS: From 2017 to 2022, adult patients (≥18 years) admitted to the medical, intermediate, and critical care units in a 6-hospital system were evaluated. SCAI B cardiogenic shock was defined as hypotension (systolic ≤90/mean ≤65 mm Hg) or hypoperfusion (lactate 2–5 mEq/L). Cardiac arrest, use of circulatory support, and noncardiac etiologies were excluded. The composite primary end point included transfer to a higher level of care, SCAI stage escalation, or in-hospital mortality. Multivariable analysis and mixed-effects regression models were used. RESULTS: During this period, 500 patients (median age, 76 years; 56% men; 79% White) developed SCAI B cardiogenic shock (hypotension 18%, hypoperfusion 82%). The most common etiologies were heart failure (37%), arrhythmia (23%), and acute myocardial infarction (13%). The primary composite end point was noted in 135 patients (deterioration cohort). The deterioration cohort had comparable baseline characteristics to those who recovered, but before the primary outcome, had lower blood pressures, higher rates of renal (60% versus 33%) and hepatic (15% versus 4%) injury, less negative fluid balance (−0.30 versus −0.68 L), and greater diuretic resistance (21% versus 2%; P <0.001). In a multivariable analysis, acute kidney injury—adjusted odds ratio 2.17 (95% CI, 1.11–4.22); P =0.02—and diuretic resistance—adjusted odds ratio 9.55 (95% CI, 2.61–34.89); P =0.001—were independently predictive of clinical deterioration. Patients with isolated hypotension had worse outcomes compared with those with isolated hypoperfusion. CONCLUSIONS: Among patients with SCAI B cardiogenic shock, a quarter of the population experienced clinical deterioration. Acute kidney injury and diuretic resistance in the preceding 24 hours were independently predictive of developing the primary end point.